Greger is licensed as a general practitioner specializing in clinical nutrition
New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects 23andMe turns research into useful genetic insights, now offering a new GLP-1 report and interactive tool through 23andMe Total Health PALO ALTO, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies genetic predictors for GLP-1 weight loss efficacy and side effects
As a result, compounded versions will generally no longer be available, except in limited patient-specific circumstances permitted under state and federal regulations
BMJ 2008
Oral versions may help, but adoption lags despite benefits for heart, metabolism, and liver
"And they came back at the end of the talks saying: 'Look, the bottom line is the comorbidities are obesity, age, for certain circumstances gender, hypertension, heart disease, being treated for cancer'those are the comorbidities that are going to be exactly the same [in the next pandemic]," he said